About the Authors
- Jeet Gandhi
-
Contributed equally to this work with: Jeet Gandhi, Jianling Zhang
Affiliation Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
- Jianling Zhang
-
Contributed equally to this work with: Jeet Gandhi, Jianling Zhang
Affiliation Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
- Yang Xie
-
Affiliation Department of Clinical Sciences, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
- Junichi Soh
-
Affiliation Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
- Hisayuki Shigematsu
-
Affiliation Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
- Wei Zhang
-
Affiliation Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
- Hiromasa Yamamoto
-
Affiliation Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
- Michael Peyton
-
Affiliation Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
- Luc Girard
-
Affiliation Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
- William W. Lockwood
-
Affiliation Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
- Wan L. Lam
-
Affiliation Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
- Marileila Varella-Garcia
-
Affiliation Department of Internal Medicine, University of Colorado Cancer Center, Aurora, Colorado, United States of America
- John D. Minna
-
Affiliations Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America, Department of Pharmacology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
- Adi F. Gazdar
-
* E-mail: adi.gazdar@utsouthwestern.edu
Affiliations Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America, Department of Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States of America
Competing Interests
Dr. Gazdar is a paid consultant/lecturer for AstraZeneca PLC. Dr. Garcia recieves Research Funding >10,000 from AstraZeneca, Genentech and OSI; Honorarium <10,000 from Roche. Dr. Minna receives research support from AstraZeneca PLC.
Author Contributions
Conceived and designed the experiments: JKG JZ JS HS HY MP LG WWL WLL MG JDM AFG. Performed the experiments: JKG JZ JS HS WZ HY MP WWL. Analyzed the data: JKG JZ YX JS LG WWL MG AFG. Contributed reagents/materials/analysis tools: WLL MG JDM. Wrote the paper: JKG JZ YX JS WZ HY WWL WLL MG JDM AFG.